These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 20023922

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation.
    Roy S, Maheswari PU, Lutz M, Spek AL, den Dulk H, Barends S, van Wezel GP, Hartl F, Reedijk J.
    Dalton Trans; 2009 Dec 28; (48):10846-60. PubMed ID: 20023915
    [Abstract] [Full Text] [Related]

  • 5. Antiproliferative activity of dmoPTA-Ru(II) complexes against human solid tumor cells.
    Ríos-Luci C, León LG, Mena-Cruz A, Pérez-Roth E, Lorenzo-Luis P, Romerosa A, Padrón JM.
    Bioorg Med Chem Lett; 2011 Aug 01; 21(15):4568-71. PubMed ID: 21719285
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis and biological studies of some gold(I) complexes containing functionalised alkynes.
    Schuh E, Valiahdi SM, Jakupec MA, Keppler BK, Chiba P, Mohr F.
    Dalton Trans; 2009 Dec 28; (48):10841-5. PubMed ID: 20023914
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Non-classical anticancer agents: synthesis and biological evaluation of zinc(II) heteroleptic complexes.
    Liguori PF, Valentini A, Palma M, Bellusci A, Bernardini S, Ghedini M, Panno ML, Pettinari C, Marchetti F, Crispini A, Pucci D.
    Dalton Trans; 2010 May 07; 39(17):4205-12. PubMed ID: 20390185
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Markedly different cytotoxicity of the two enantiomers of C(2)-symmetrical Ti(IV) phenolato complexes; mechanistic implications.
    Manna CM, Tshuva EY.
    Dalton Trans; 2010 Feb 07; 39(5):1182-4. PubMed ID: 20104339
    [Abstract] [Full Text] [Related]

  • 15. Development of bimetallic titanocene-ruthenium-arene complexes as anticancer agents: relationships between structural and biological properties.
    Pelletier F, Comte V, Massard A, Wenzel M, Toulot S, Richard P, Picquet M, Le Gendre P, Zava O, Edafe F, Casini A, Dyson PJ.
    J Med Chem; 2010 Oct 14; 53(19):6923-33. PubMed ID: 20822096
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dual anti-angiogenic and cytotoxic properties of ruthenium(III) complexes containing pyrazolato and/or pyrazole ligands.
    Sun RW, Ng MF, Wong EL, Zhang J, Chui SS, Shek L, Lau TC, Che CM.
    Dalton Trans; 2009 Dec 28; (48):10712-6. PubMed ID: 20023898
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
    Hotze AC, Bacac M, Velders AH, Jansen BA, Kooijman H, Spek AL, Haasnoot JG, Reedijk J.
    J Med Chem; 2003 Apr 24; 46(9):1743-50. PubMed ID: 12699392
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.